Author:
Serebruany Victor L.,Choi Sun Young,Kim Moo Hyun
Subject
Cardiology and Cardiovascular Medicine
Reference12 articles.
1. Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects;Kosoglou;Eur. J. Clin. Pharmacol.,2012
2. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes;Tricoci;N. Engl. J. Med.,2012
3. Vorapaxar in the secondary prevention of atherothrombotic events;Morrow;N. Engl. J. Med.,2012
4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N. Engl. J. Med.,2009
5. The FDA Ticagrelor Secondary Review. Available for download at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220192.pdf. (Assessed July 21st, 2015).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献